Codexis, Inc. (CDXS) Appoints Biopharmaceuticals Industry Veteran, Patrick Yang, Ph.D., To Board Of Directors
2/27/2014 9:42:41 AM
REDWOOD CITY, Calif., Feb. 27, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced the appointment of Patrick Yang, Ph.D., to its board of directors. Dr. Yang brings significant experience in pharmaceutical manufacturing and process development to the Codexis board, following several executive leadership roles within the pharmaceutical industry.
Help employers find you! Check out all the jobs and post your resume.
comments powered by